| MR编号 | PT/H/2134/002 |
|---|
| 药品名称 | Teicoplanina Accordpharma |
|---|
| 活性成分 | - teicoplanin 400.0 mg/3 ml
|
|---|
| 剂型 | Powder and solvent for solution for infusion |
|---|
| 上市许可持有人 | Astron Research Limited |
|---|
| 参考成员国 - 产品名称 | Portugal (PT) |
|---|
| 互认成员国 - 产品名称 | - Bulgaria (BG)
- Croatia (HR)
- Czechia (CZ)
Teicoplanin 400 mg/3 ml Powder and solvent for solution for injection/infusion or oral solution - Germany (DE)
Teicoplanin 400mg / 3ml Pulver und Lösungsmittel zur Herstellung einer Injektions- bzw. Infusionslösung und einer Lösung zum Einnehmen - Finland (FI)
- France (FR)
- Hungary (HU)
- Ireland (IE)
- Italy (IT)
- Netherlands (NL)
- Poland (PL)
Teicoplanin Accord - Romania (RO)
Teicoplanină Accord 400 mg/3 ml pulbere şi solvent pentru soluţie injectabilă/perfuzabilă sau soluţie orală - Sweden (SE)
- United Kingdom (GB)
|
|---|
| 许可日期 | 2020/01/08 |
|---|
| 最近更新日期 | 2020/02/12 |
|---|
| 药物ATC编码 | |
|---|
| 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Withdrawn（注：已撤市） |
|---|